Fangyuan Chen

9PUBLICATIONS
69CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsGene and molecular therapySensory processes, perception and performance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 19, 2026
Use of ctDNA in Older Women with ER+ Breast Cancer to Facilitate Surgical De-escalation: A Prospective, Hybrid-Decentralized Trial with Correlative Studies.

Neil Carleton, Alexander C Chang, Fangyuan Chen

|Nov 14, 2025
Mixed Molecular Subtypes Coexist in Estrogen Receptor Heterogeneous Primary Breast Cancers.

Julia Foldi, Kaitlyn Xiong, Matthew Liu

|Dec 20, 2024
The EstroGene2.0 database for endocrine therapy response and resistance in breast cancer.

Zheqi Li, Fangyuan Chen, Li Chen

|Nov 18, 2024
Matching patients to clinical trials with large language models.

Qiao Jin, Zifeng Wang, Charalampos S Floudas

|Nov 09, 2024
Immune infiltration correlates with transcriptomic subtypes in primary estrogen receptor positive invasive lobular breast cancer.

Fangyuan Chen, Sayali Onkar, Jian Zou

|Jul 23, 2024
Hidden flaws behind expert-level accuracy of multimodal GPT-4 vision in medicine.

Qiao Jin, Fangyuan Chen, Yiliang Zhou

Pageof 2

Frequent Collaborators

6 joint publications

Adrian V Lee

5 joint publications

Steffi Oesterreich

3 joint publications

Julia Foldi

2 joint publications

Neil Carleton